UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 9, 2016 (December 8, 2016)

 

KMG Chemicals, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

TEXAS

 

001-35577

 

75-2640529

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

 

 

 

 

300 Throckmorton Street, Fort Worth, Texas

 

76102

(Address of principal executive offices)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code (817) 761-6100

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 


Item 5.07

Submission of Matters to a Vote of Security Holders.

The annual shareholders meeting was held on December 8, 2016. At that meeting, the shareholders voted to elect all the nominees to our board of directors as follows:

 

 

 

 

 

 

 

Votes

 

Nominees

 

Votes For

 

 

Withheld

 

Gerald G. Ermentrout

 

 

10,130,270

 

 

 

127,183

 

Christopher T. Fraser

 

 

10,151,858

 

 

 

105,595

 

George W. Gilman

 

 

10,137,181

 

 

 

120,272

 

Robert Harrer

 

 

10,140,391

 

 

 

117,062

 

John C. Hunter, III

 

 

9,662,935

 

 

 

594,518

 

Fred C. Leonard, III

 

 

4,931,205

 

 

 

5,326,248

 

Karen A. Twitchell

 

 

10,158,554

 

 

 

98,899

 

 

The foregoing persons compose our full board of directors.

 

The shareholders also voted to approve the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2017. The vote was 10,799,939 for, 166,201 against and 149 abstentions. The shareholders also voted to approve our executive compensation.  The vote was 8,135,652 for, 2,116,947 against, 4,854 abstentions and 708,836 broker non-votes.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

KMG Chemicals, Inc.

 

 

 

 

By:

/s/ Christopher T. Fraser

Date: December 9, 2016

 

Christopher T. Fraser,

 

 

President and Chief Executive Officer